The effect of wearing an activity tracker on the length of hospital stay for gastrointestinal cancer patients: A randomised controlled trial (the Fit-4-Home Trial)

Not Applicable

Completed

• Conditions: Gastrointestinal Cancer; Cancer - Liver; Cancer - Stomach; Cancer - Pancreatic

• Registration Number: ACTRN12619000194167
• Lead Sponsor: Sydney Local Health District

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2019-02-12
• Study Completion: 2021-03-10
• Last Update Posted: 8 July 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 96

Inclusion Criteria

Patients must be adults aged 18-85 years and scheduled to undergo elective surgery for liver, stomach and pancreatic cancer with one of the participating surgeons at the Royal Prince Alfred Hospital, or the Chris O'Brien Lifehouse, Sydney.

Exclusion Criteria

Patients will be excluded from participating in this trial if they present:
•Cognitive impairment such that they are unable to provide informed consent.
•Unable to place a Fitbit on patient’s wrist (including size and/or allergy).
•Neurological deficit which requires assistance in mobilisation (e.g. stroke, post limb amputation).
•Insufficient English language to complete outcome measures

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To assess if wearing an activity tracker during the inpatient stay impacts the length of hospital stay (defined as the duration of inpatient hospital stay (in days) from admission to the ward (day 0) until hospital discharge, data obtained from patient hospital records).[ Time of discharge from hospital.]